z-logo
open-access-imgOpen Access
Molecular Mechanism of Target Recognition by Subtilin, a Class I Lanthionine Antibiotic
Author(s) -
Judicaël Parisot,
Sarah Carey,
Eefjan Breukink,
Weng C. Chan,
Arjan Narbad,
Boyan B. Bonev
Publication year - 2008
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.00836-07
Subject(s) - nisin , lipid ii , lantibiotics , lanthionine , in vivo , biochemistry , chemistry , succinylation , in vitro , biology , peptidoglycan , microbiology and biotechnology , antimicrobial , peptide , amino acid , cell wall , genetics , lysine
The increasing resistance of human pathogens to conventional antibiotics presents a growing threat to the chemotherapeutic management of infectious diseases. The lanthionine antibiotics, still unused as therapeutic agents, have recently attracted significant scientific interest as models for targeting and management of bacterial infections. We investigated the action of one member of this class, subtilin, which permeabilizes lipid membranes in a lipid II-dependent manner and binds bactoprenyl pyrophosphate, akin to nisin. The role the C and N termini play in target recognition was investigated in vivo and in vitro by using the natural N-terminally succinylated subtilin as well as enzymatically truncated subtilin variants. Fluorescence dequenching experiments show that subtilin induces leakage in membranes in a lipid II-dependent manner and that N-succinylated subtilin is roughly 75-fold less active. Solid-state nuclear magnetic resonance was used to show that subtilin forms complexes with membrane isoprenyl pyrophosphates. Activity assays in vivo show that the N terminus of subtilin plays a critical role in its activity. Succinylation of the N terminus resulted in a 20-fold decrease in its activity, whereas deletion of N-terminal Trp abolished activity altogether.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here